COURT-RULING ·Filed Aug 31, 2026

SNY

Sanofi
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago CourtView Ruling on CourtListener
Court ruling (district)
Actionable Insight • Neutral

This dismissal removes a low-probability litigation overhang for Sanofi, but the case had no stated financial exposure and was dismissed early. No material impact on Sanofi's stock is expected. Monitor for any appeal by the plaintiff, though the dismissal with prejudice makes reversal unlikely.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
SNY ▼ -8.16% at T+20d
NEUTRAL call ✗ call lost -8.16% · α vs SPY -7.97% · entry $44.36 → $40.74
Next anchor: T+60d in 7w
Latest observation: T+21 -3.72% FF3 residual α
Entry anchored
Aug 28, 07:00 PM ET
via 1-min bar
T+1d
+0.02%
call +0.02% · α +0.71%
$44.37
settled 5w ago
T+5d
-2.72%
call -2.72% · α -2.57%
$43.16
settled 28d ago
T+20d
-8.16%
call -8.16% · α -7.97%
$40.74
settled 4d ago
T+60d
—
call — · α —
—
in 7w

Price Chart

Loading chart...

Executive Summary

The District of Oregon adopted a magistrate judge's recommendation and dismissed with prejudice a lawsuit against Sanofi and co-defendants. The ruling removes litigation uncertainty for Sanofi regarding this specific case, which was dismissed at the pleading stage with no damages awarded or sought in the opinion text. Given the dismissal of a case with no stated financial exposure, the impact on Sanofi is minimal and neutral.

Court Ruling Details

Ruling Date
Aug 31, 2026
Court
United States District Court for the District of Oregon
Court Level
District
Judge
Amy M. Baggio
Case Type
other
Ruling Type
final judgment
Outcome
WIN — ruling favors this company
Will It Be Appealed?
Unlikely
Precedent Risk
LOW

Key Facts

  • Case Hollingsworth v. Sanofi-Aventis US LLC et al. (3:25-cv-02308-SB) dismissed with prejudice on August 31, 2026.
  • The court adopted the magistrate judge's Findings and Recommendation granting defendants' motions to dismiss.
  • No damages, settlement amounts, or financial exposure figures are stated in the opinion text.
  • The ruling is a final judgment in favor of Sanofi and co-defendants, ending the case at the district court level.

Financial Impact

No damages awarded or pleaded amounts stated in the opinion. The case was dismissed at the pleading stage with no financial exposure quantified.

Risk Factors

  • Plaintiff could appeal the dismissal to the Ninth Circuit, though the dismissal with prejudice and adoption of the magistrate's recommendation suggest a low probability of success on appeal.
  • No other material risks identified from this ruling.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
57% bullish (30 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-5b96153d4d-SNY
9 reports for SNY
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+20▲ +4.04%Jul 31, 2026
Filters
Rows
Reports for SNY — sortable, filterable
TypeNow
Aug 31, 2026
4w ago
Court Ruling
NEUTRAL ★ 2/10
$44.36 $40.74▼ −8.16%▼ −7.97%$39.92 (−10.01%)
Aug 17, 2026
6w ago
Court Ruling
BULLISH ★ 4/10
$44.41 $42.40▼ −4.53%▼ −2.55%$39.92 (−10.11%)
Aug 12, 2026
7w ago
Court Ruling
NEUTRAL ★ 2/10
$43.71 $42.72▼ −2.26%▼ −0.37%$39.92 (−8.67%)
Jul 31, 2026
9w ago
Court Ruling
BULLISH ★ 5/10
$43.08 $44.82▲ +4.04%▲ +1.05%$39.92 (−7.34%)
Jul 30, 2026
9w ago
6-K
MIXED ★ 6/10
$42.89 $44.84▲ +4.55%▲ +0.58%$39.92 (−6.92%)
Jul 27, 2026
9w ago
6-K
BEARISH ★ 5/10
$44.00 $45.69▼ −3.84%▼ −0.54%$39.92 (+9.27%)
Jul 17, 2026
11w ago
6-K
BULLISH ★ 6/10
$44.66 $43.72▼ −2.10%▼ −6.55%$39.92 (−10.61%)
Jul 7, 2026
12w ago
6-K
BULLISH ★ 5/10
$42.98 $42.95▼ −0.07%▼ −1.40%$39.92 (−7.12%)
Apr 13, 2026
24w ago
Court Ruling
NEUTRAL ★ 3/10
$44.49 $42.50▼ −4.48%▼ −12.20%$39.92 (−10.28%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access